PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1447059
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1447059
Blood Transfusion Diagnostics Market Forecasts to 2030 - Global Analysis By Product, Application, End User and By Geography
According to Stratistics MRC, the Global Blood Transfusion Diagnostics Market is accounted for $4.8 billion in 2023 and is expected to reach $8.5 billion by 2030 growing at a CAGR of 8.5% during the forecast period. This market serves a critical role in ensuring the safety and efficacy of blood transfusions by detecting infectious diseases, identifying blood groups, and assessing compatibility between donors and recipients. These diagnostics help identify potential pathogens such as HIV, hepatitis B and C, and syphilis, reducing the risk of transfusion-transmitted infections. Additionally, blood typing and crossmatching tests ensure compatibility between donor and recipient blood, minimizing the likelihood of adverse reactions during transfusions.
According to an article published by Medscape on March 2022, it was reported that the prevalence of Hemophilia A is 20.6 cases per 100,000 males in the United States. According to an article published by the Canadian Hemophilia Society (CHS) in February 2022, it was reported that the total number of Canadian suffering from Hemophilia A and B is estimated to be 3,100.
Market Dynamics:
Driver:
Rise in blood donor screening programs
With an increasing emphasis on public health and safety standards, blood donor screening programs have become more widespread, aiming to detect infectious diseases and other health conditions that could compromise the integrity of donated blood. These screening programs employ advanced diagnostic technologies such as nucleic acid testing (NAT), serological testing, and immunoassays to identify potential risks associated with donated blood, thus minimizing the chances of transfusion-transmitted infections.
Restraint:
High cost of equipment and tests
Blood transfusion diagnostics rely heavily on specialized equipment and sophisticated tests to ensure the safety and compatibility of donated blood for transfusion. These tools, ranging from automated analyzers to reagents and consumables, incur substantial expenses in procurement and maintenance. The complexity of diagnostic procedures necessitates skilled personnel for operation and interpretation, further adding to the overall costs. However, for healthcare facilities, especially in resource-constrained settings or developing countries, the financial burden of investing in such equipment and conducting tests can be prohibitive, limiting their capacity to offer comprehensive blood transfusion services.
Opportunity:
Increasing healthcare expenditure
As healthcare expenditure rises, there is a corresponding increase in the demand for advanced medical technologies and procedures, including blood transfusion diagnostics. This heightened expenditure allows healthcare facilities to invest in state-of-the-art equipment and diagnostic tools for ensuring the safety and efficacy of blood transfusions. Moreover, as healthcare budgets expand, there's greater focus on improving patient outcomes and reducing the risks associated with blood transfusions, such as transfusion-transmitted infections and adverse reactions.
Threat:
Limited access to advanced technologies
Access to cutting-edge technologies such as nucleic acid amplification tests (NAT), next-generation sequencing (NGS), and automated blood screening systems is essential for accurate and efficient blood transfusion diagnostics. In many regions, especially in developing countries or remote areas, healthcare facilities may lack the infrastructure, resources, or trained personnel to adopt these advanced technologies. As a result, the ability to perform timely and precise blood screening and compatibility testing may be compromised, leading to potential risks such as transfusion-transmitted infections or incompatible blood transfusions.
Covid-19 Impact:
The demand for blood transfusions increased due to Covid-related complications, such as severe respiratory distress or other critical conditions requiring transfusion support. This surge in demand placed pressure on diagnostic services to ensure the safety and compatibility of blood products. On the other hand, pandemic-related restrictions, fear of infection, and disruptions in healthcare services led to reduced blood donations, affecting the blood supply chain. Consequently, blood transfusion diagnostic companies faced challenges in maintaining adequate inventory levels and ensuring timely testing for donated blood, thus intensifying the need for efficient diagnostic solutions and technologies to safeguard transfusion safety amidst the pandemic's uncertainties.
The hemoglobinometers segment is expected to be the largest during the forecast period
Hemoglobinometers segment is expected to be the largest during the forecast period, as it provides quick and reliable assessments of hemoglobin concentration, aiding in the screening of blood donors and ensuring the safety and efficacy of transfusions. By enabling healthcare professionals to rapidly determine hemoglobin levels, hemoglobinometers streamline the blood donation process, reducing the risk of transfusion reactions and improving overall patient outcomes. Additionally, these devices are portable and user-friendly, making them accessible in a variety of healthcare settings, including remote or resource-limited areas.
The blood grouping segment is expected to have the highest CAGR during the forecast period
Blood Grouping segment is expected to have the highest CAGR during the forecast period. Accurate blood typing and crossmatching are critical to prevent adverse reactions during transfusions. With advancements in technology and techniques for blood grouping, such as the introduction of automated systems and molecular testing methods, healthcare facilities can efficiently determine blood types and screen for irregular antibodies. This has significantly reduced the risk of transfusion reactions and improved patient outcomes. Additionally, the increasing demand for blood products due to rising surgical procedures, trauma cases, and chronic diseases has further propelled the regional growth of the Blood Transfusion Diagnostics Market.
Region with largest share:
Over the projected period, the North American area held the largest share due to rising disposable income, improved health infrastructure, rising health consciousness, and favorable reimbursement policies. The American Red Cross estimates that 16 million blood components are transfused annually in the United States. Additionally, this region's high rate of transfusion-transmitted infections and rising blood donation awareness are predicted to fuel market expansion.
Region with highest CAGR:
Due to the rising number of patients with anemia which needs red blood cell transfusion for therapy, Asia Pacific is predicted to experience sustainable growth during the extended period, which is expected to drive up demand for blood transfusion diagnostics. Blood products and entire blood transfusions are in high demand in the area due to the rising prevalence of blood-related conditions such as hemophilia, cancer, thrombocytopenia, etc., and chronic kidney disease (CKD).
Key players in the market
Some of the key players in Blood Transfusion Diagnostics market include Abbott Laboratories, BAG Healthcare GmBH, Bio-Rad Laboratories, Inc, Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Grifols S.A., Hologic, Inc, Immucor, Inc, Ortho Clinical Diagnostics and Siemens Healthcare Private Limited.
Key Developments:
In February 2023, MedGenome Labs launched FSHD1 genetic screening test to assess the genetic changes in patients at early stages to facilitate better treatment options. Various government initiatives and approvals are also encouraging players to enter the market.
In November 2022, Werfen entered into an agreement with TPG to acquire Immucor, Inc. Immucor, Inc., is a global company with a wide range of portfolio in transfusion diagnostics products. This will help the company to widen its product range by including the specialized diagnostics solution of Immucor, Inc.
Products Covered:
- Hemoglobinometers
- Instruments
- Plasma
- Reagents & kits
- Other Products
Applications Covered:
- Disease Screening
- Blood Grouping
- Other Applications
End Users Covered:
- Diagnostic Laboratories
- Hospitals
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Product Analysis
- 3.7 Application Analysis
- 3.8 End User Analysis
- 3.9 Emerging Markets
- 3.10 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Blood Transfusion Diagnostics Market, By Product
- 5.1 Introduction
- 5.2 Hemoglobinometers
- 5.3 Instruments
- 5.4 Plasma
- 5.5 Reagents & kits
- 5.6 Other Products
6 Global Blood Transfusion Diagnostics Market, By Application
- 6.1 Introduction
- 6.2 Disease Screening
- 6.2.1 Molecular Disease Screening
- 6.2.2 Serological Disease Screening
- 6.3 Blood Grouping
- 6.4 Other Applications
7 Global Blood Transfusion Diagnostics Market, By End User
- 7.1 Introduction
- 7.2 Diagnostic Laboratories
- 7.3 Hospitals
- 7.4 Other End Users
8 Global Blood Transfusion Diagnostics Market, By Geography
- 8.1 Introduction
- 8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
- 8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
- 8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa
9 Key Developments
- 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 9.2 Acquisitions & Mergers
- 9.3 New Product Launch
- 9.4 Expansions
- 9.5 Other Key Strategies
10 Company Profiling
- 10.1 Abbott Laboratories
- 10.2 BAG Healthcare GmBH
- 10.3 Bio-Rad Laboratories, Inc
- 10.4 Danaher Corporation
- 10.5 DiaSorin S.p.A.
- 10.6 F. Hoffmann-La Roche Ltd
- 10.7 Grifols S.A.
- 10.8 Hologic, Inc
- 10.9 Immucor, Inc
- 10.10 Ortho Clinical Diagnostics
- 10.11 Siemens Healthcare Private Limited
List of Tables
- Table 1 Global Blood Transfusion Diagnostics Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
- Table 3 Global Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
- Table 4 Global Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
- Table 5 Global Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
- Table 6 Global Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
- Table 7 Global Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
- Table 8 Global Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
- Table 9 Global Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
- Table 10 Global Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
- Table 11 Global Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
- Table 12 Global Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
- Table 13 Global Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 14 Global Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
- Table 15 Global Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
- Table 16 Global Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 17 Global Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 18 North America Blood Transfusion Diagnostics Market Outlook, By Country (2021-2030) ($MN)
- Table 19 North America Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
- Table 20 North America Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
- Table 21 North America Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
- Table 22 North America Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
- Table 23 North America Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
- Table 24 North America Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
- Table 25 North America Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
- Table 26 North America Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
- Table 27 North America Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
- Table 28 North America Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
- Table 29 North America Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
- Table 30 North America Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 31 North America Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
- Table 32 North America Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
- Table 33 North America Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 34 North America Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 35 Europe Blood Transfusion Diagnostics Market Outlook, By Country (2021-2030) ($MN)
- Table 36 Europe Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
- Table 37 Europe Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
- Table 38 Europe Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
- Table 39 Europe Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
- Table 40 Europe Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
- Table 41 Europe Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
- Table 42 Europe Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
- Table 43 Europe Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
- Table 44 Europe Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
- Table 45 Europe Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
- Table 46 Europe Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
- Table 47 Europe Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 48 Europe Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
- Table 49 Europe Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
- Table 50 Europe Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 51 Europe Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 52 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Country (2021-2030) ($MN)
- Table 53 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
- Table 54 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
- Table 55 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
- Table 56 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
- Table 57 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
- Table 58 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
- Table 59 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
- Table 60 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
- Table 61 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
- Table 62 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
- Table 63 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
- Table 64 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 65 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
- Table 66 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
- Table 67 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 68 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 69 South America Blood Transfusion Diagnostics Market Outlook, By Country (2021-2030) ($MN)
- Table 70 South America Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
- Table 71 South America Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
- Table 72 South America Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
- Table 73 South America Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
- Table 74 South America Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
- Table 75 South America Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
- Table 76 South America Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
- Table 77 South America Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
- Table 78 South America Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
- Table 79 South America Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
- Table 80 South America Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
- Table 81 South America Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 82 South America Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
- Table 83 South America Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
- Table 84 South America Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 85 South America Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 86 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Country (2021-2030) ($MN)
- Table 87 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
- Table 88 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
- Table 89 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
- Table 90 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
- Table 91 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
- Table 92 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
- Table 93 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
- Table 94 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
- Table 95 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
- Table 96 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
- Table 97 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
- Table 98 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 99 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
- Table 100 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
- Table 101 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 102 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
